BioStone > MH Bacterin-toxoid Vaccine Collaboration Opportunities > Standalone Mannheimia haemolytica Vaccine Opportunity

Standalone Mannheimia haemolytica Vaccine Opportunity

BioStone Animal Health is seeking U.S. and international partners to support the development and future commercialization of a standalone Mannheimia haemolytica bacterin-toxoid for cattle.

The program is based on USDA Product Code 7905.02 and the historical trade name LEUKOTOX-MH. The product contains leukotoxoid and cell-associated antigens from multiple isolates and was developed to help protect cattle against respiratory disease caused by M. haemolytica.

BioStone welcomes discussions with distributors, vaccine manufacturers, licensing partners, and other animal-health companies interested in co-development, manufacturing, regulatory support, or future commercialization.

Discuss a Collaboration

Contact Us

Additional information about Product Code 7905.02 is provided below.

PRODUCT INFORMATION

Product true name: Mannheimia Haemolytica Bacterin-Toxoid,

USDA Product Code: 7905.02

Tradename: LEUKOTOX-MH

MH bacterin-toxoid is recommended for vaccination of healthy cattle 60 days of age or older against respiratory disease due to M. haemolytica.

BENEFITS

  • Convenient, ready-to-use, no mixing.
  • Proven effectiveness and performance in challenge studies.
  • Contains leukotoxoid and cell-associated antigens from multiple isolates.

INDICATION

This product has been shown to be effective for the vaccination of healthy cattle 60 days of age or older against respiratory disease due to Mannheimia haemolytica. The duration of immunity has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov​.

STORAGE & HANDLING

Store at 2° – 8° C. Do not freeze. Mix well before use. Use entire contents when first opened.​

DOSES & ADMINISTRATION

Shake well. Inject 2 mL subcutaneously in the neck. Repeat in 14-28 days. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.

IMPORTANT SAFETY INFORMATION

Do not vaccinate within 21 days of slaughter. Do not mix with other products. In case of anaphylaxis and other hypersensitivity reactions, administer epinephrine and symptomatic treatments immediately. Hypersensitivity reactions, including delayed hypersensitivity, or death may occur with a biological product and can cause reduced milk production in lactating dairy cattle. This product has not been tested in pregnant animals. Following subcutaneous use, persistent swelling may occur at the injection site. This product contains residual of formaldehyde and thimerosal as preservatives. For veterinary use only. In case of human exposure, contact a physician.